Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Cyrawel Cytarabine Injection 100 mg
Cyrawel is a potent chemotherapeutic agent designed for the treatment of acute leukemia and lymphoma. It contains Cytarabine, which acts by inhibiting DNA synthesis, effectively halting cancer cell proliferation and inducing apoptosis.
Uses of Cyrawel Cytarabine Injection 100 mg
Treatment of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)
Management of non-Hodgkin’s lymphoma
Used in induction, consolidation, and maintenance chemotherapy regimens
Benefits of Cyrawel Cytarabine Injection 100 mg
Highly effective in leukemia and lymphoma treatment
Direct inhibition of DNA replication in cancer cells
Essential component of standard chemotherapy protocols
Administered via IV or SC for rapid action
Mechanism of Action of Cyrawel Cytarabine Injection 100 mg
Cytarabine is a pyrimidine nucleoside analog that integrates into the DNA strand during replication, leading to chain termination and apoptosis of rapidly dividing cancer cells. This mechanism makes it a cornerstone in hematologic cancer treatment.